Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
Acta Obstetricia Et Gynecologica Scandinavica|October 13, 2020
Carboplatin plus paclitaxel weekly dose-dense chemotherapy for high-grade ovarian cancer: A re-evaluationRoy Kessous, Emad Matanes, Ido Laskov, et al.
Gynecologic Oncology|November 23, 2005
Insulin-like growth factor receptor I targeting in epithelial ovarian cancerWalter H Gotlieb, Ilan Bruchim, Jing Gu, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open SurgeryYossi Tzur, Yoav Brezinov, Tomer Bar-Noy, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|August 30, 2020
Similar Overall Survival Using Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients Aged Over 75 Years with High-Grade Ovarian CancerSabrina Piedimonte, Roy Kessous, Ido Laskov, et al.
Gynecologic Oncology|May 17, 2005
Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancerWalter H Gotlieb, Angela Chetrit, Joseph Menczer, et al.
Obstetrics and Gynecology|October 11, 2003
Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancerWalter H Gotlieb, Mario E Beiner, Bruria Shalmon, et al.
Gynecologic Oncology|December 6, 2000
E-Cadherin complex protein expression and survival in ovarian carcinomaB Davidson, W H Gotlieb, G Ben-Baruch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 20, 2019
Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignmentRoy Kessous, Jeffrey How, Jeremie Abitbol, et al.
Pageof 18